152 related articles for article (PubMed ID: 33524183)
1. Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer.
Lee RT; Kwon N; Wu J; To C; To S; Szmulewitz R; Tchekmedyian R; Holmes HM; Olopade OI; Stadler WM; Von Roenn J
Cancer; 2021 Jun; 127(11):1827-1835. PubMed ID: 33524183
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
3. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011.
Qato DM; Wilder J; Schumm LP; Gillet V; Alexander GC
JAMA Intern Med; 2016 Apr; 176(4):473-82. PubMed ID: 26998708
[TBL] [Abstract][Full Text] [Related]
4. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.
Qato DM; Alexander GC; Conti RM; Johnson M; Schumm P; Lindau ST
JAMA; 2008 Dec; 300(24):2867-78. PubMed ID: 19109115
[TBL] [Abstract][Full Text] [Related]
5. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements.
Wolf CPJG; Rachow T; Ernst T; Hochhaus A; Zomorodbakhsch B; Foller S; Rengsberger M; Hartmann M; Hübner J
J Cancer Res Clin Oncol; 2022 Feb; 148(2):461-473. PubMed ID: 33864520
[TBL] [Abstract][Full Text] [Related]
6. Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation.
Hanigan MH; Dela Cruz BL; Thompson DM; Farmer KC; Medina PJ
J Oncol Pharm Pract; 2008 Sep; 14(3):123-30. PubMed ID: 18719067
[TBL] [Abstract][Full Text] [Related]
7. Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.
Ali-Shtayeh MS; Jamous RM; Salameh NM; Jamous RM; Hamadeh AM
J Ethnopharmacol; 2016 Jul; 187():104-22. PubMed ID: 27125594
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of drug-herb and drug-supplement interactions in older adults: a cross-sectional survey.
Agbabiaka TB; Spencer NH; Khanom S; Goodman C
Br J Gen Pract; 2018 Oct; 68(675):e711-e717. PubMed ID: 30249608
[TBL] [Abstract][Full Text] [Related]
9. Herbal supplement usage among cancer patients: A questionnaire-based survey.
Kanimozhi T; Hindu K; Maheshvari Y; Khushnidha YG; Kumaravel M; Srinivas KS; Manickavasagam M; Mangathayaru K
J Cancer Res Ther; 2021; 17(1):136-141. PubMed ID: 33723144
[TBL] [Abstract][Full Text] [Related]
10. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration Hospital.
Lee AH; Ingraham SE; Kopp M; Foraida MI; Jazieh AR
Am J Clin Oncol; 2006 Apr; 29(2):178-82. PubMed ID: 16601439
[TBL] [Abstract][Full Text] [Related]
11. Dietary supplement usage by patients with cancer undergoing chemotherapy: does prognosis or cancer symptoms predict usage?
Bardia A; Greeno E; Bauer BA
J Support Oncol; 2007 Apr; 5(4):195-8. PubMed ID: 17500507
[TBL] [Abstract][Full Text] [Related]
12. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
[TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.
Escudero-Vilaplana V; Collado-Borrell R; Gómez Martínez-Sagrera P; Villanueva-Bueno C; Revuelta-Herrero JL; Gonzalez-Haba E; Hoyo-Muñoz Á; Jerez Gilarranz Y; Marzal-Alfaro B; Herranz A; Martin M; Sanjurjo M
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2855-2882. PubMed ID: 35790560
[TBL] [Abstract][Full Text] [Related]
14. Herbal and vitamin supplement use in a prostate cancer screening population.
Barqawi A; Gamito E; O'Donnell C; Crawford ED
Urology; 2004 Feb; 63(2):288-92. PubMed ID: 14972473
[TBL] [Abstract][Full Text] [Related]
15. Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness.
Eyal S; Rasaby S; Ekstein D
Epilepsy Behav; 2014 Feb; 31():369-76. PubMed ID: 24211058
[TBL] [Abstract][Full Text] [Related]
16. Herbal supplement use by persons aged over 50 years in Britain: frequently used herbs, concomitant use of herbs, nutritional supplements and prescription drugs, rate of informing doctors and potential for negative interactions.
Canter PH; Ernst E
Drugs Aging; 2004; 21(9):597-605. PubMed ID: 15260514
[TBL] [Abstract][Full Text] [Related]
17. Are emergency department patients at risk for herb-drug interactions?
Rogers EA; Gough JE; Brewer KL
Acad Emerg Med; 2001 Sep; 8(9):932-4. PubMed ID: 11535489
[TBL] [Abstract][Full Text] [Related]
18. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance.
Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C
J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392
[TBL] [Abstract][Full Text] [Related]
19. Comparison of eight screening tools to detect interactions between herbal supplements and oncology agents.
Shakeel F; Fang F; Kidwell KM; Marcath LA; Hertz DL
J Oncol Pharm Pract; 2020 Dec; 26(8):1843-1849. PubMed ID: 32075508
[TBL] [Abstract][Full Text] [Related]
20. Potential for interactions between dietary supplements and prescription medications.
Sood A; Sood R; Brinker FJ; Mann R; Loehrer LL; Wahner-Roedler DL
Am J Med; 2008 Mar; 121(3):207-11. PubMed ID: 18328304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
